NCT06167629View on ClinicalTrials.gov

Monocentric Observational Study on the Diagnostic and Prognostic Role of 18F-PSMA PET (PET/CT and PET/MR) in Prostate Cancer

RecruitingOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

October 13, 2022

Primary Completion Date

July 13, 2027

Study Completion Date

July 13, 2027

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

PET 18F-PSMA

Subjects will be subjected to a PET examination according to international guidelines and where requested by the specialist. In particular, patients will be administered the radiopharmaceutical 18 F PSMA. Approximately two hours after administration, the patient is positioned on the PET/CT equipment table and image acquisition begins.

Trial Locations (1)

Unknown

RECRUITING

IRC, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER